You have 9 free searches left this month | for more free features.

Histologically proved endometrial carcinoma preoperatively supposed stage I-II

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Cancer Survivor, Endometrial Carcinoma, Stage I Uterine Corpus Cancer AJCC v7 Trial in Palo Alto, San Jose (Communication

Active, not recruiting
  • Cancer Survivor
  • +6 more
  • Communication Intervention
  • +5 more
  • Palo Alto, California
  • +1 more
Oct 24, 2022

Obesity, Endometrial Carcinoma Trial in Columbus (Gentle yoga therapy, counseling intervention, educational intervention)

Active, not recruiting
  • Obesity
  • Endometrial Carcinoma
  • Gentle yoga therapy
  • +4 more
  • Columbus, Ohio
    Arthur G. James Cancer Hospital and Solove Research Institute at
Jun 3, 2022

Among Reproductive Age Gynecological and Breast Cancer

Recruiting
  • Anatomic Stage I Breast Cancer AJCC v8
  • +29 more
  • Healthcare Activity
  • Survey Administration
  • Houston, Texas
    M D Anderson Cancer Center
Nov 2, 2022

Endometrial Cancer, Endometrial Tumors, Endometrial Adenocarcinoma Trial in Istra (Laparoscopic hysterectomy with sentinel lymph

Recruiting
  • Endometrial Cancer
  • +8 more
  • Laparoscopic hysterectomy with sentinel lymph node biopsy
  • Istra, Moscow Region, Russian Federation
    Department of Gynecologic Oncology, Moscow City Oncology Hospita
Oct 8, 2021

Endometrial Adenocarcinoma Trial in Helsinki (Comparison of adjuvant therapies)

Recruiting
  • Endometrial Adenocarcinoma
  • Comparison of adjuvant therapies
  • Helsinki, Finland
    Helsinki University Hospital
Dec 8, 2022

Gastric Adenocarcinoma, Esophageal Cancer, Hepatocellular Carcinoma Trial in United States (Sacituzumab Govitecan-hziy (SG))

Completed
  • Gastric Adenocarcinoma
  • +15 more
  • Sacituzumab Govitecan-hziy (SG)
  • Aurora, Colorado
  • +11 more
Aug 10, 2021

Stage I Endometrial Carcinoma, Stage II Endometrial Carcinoma, Stage III Endometrial Carcinoma Trial in Cleveland (lymph node

Terminated
  • Stage I Endometrial Carcinoma
  • +3 more
  • lymph node mapping
  • +5 more
  • Cleveland, Ohio
    Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Ca
Aug 26, 2020

Endometrial Carcinoma, Tumor Molecular Features Screening Model Trial (open surgery, laparoscopic surgery)

Not yet recruiting
  • Endometrial Carcinoma
  • Tumor Molecular Features Screening Model
  • open surgery
  • laparoscopic surgery
  • (no location specified)
Jun 7, 2023

Endometrial Cancer, Endometrial Tumors, Obesity, Morbid Trial (Robot-assisted surgery, Laparoscopic surgery)

Not yet recruiting
  • Endometrial Cancer
  • +4 more
  • Robot-assisted surgery
  • Laparoscopic surgery
  • (no location specified)
Jul 25, 2023

Recurrent Endometrial Carcinoma, Recurrent Endometrial Endometrioid Adenocarcinoma, Refractory Endometrial Carcinoma Trial in

Recruiting
  • Recurrent Endometrial Carcinoma
  • +12 more
  • Houston, Texas
  • +1 more
Sep 22, 2022

Endometrial Endometrioid Adenocarcinoma, Stage I Uterine Corpus Cancer AJCC v8, Stage IA Uterine Corpus Cancer AJCC v8 Trial in

Active, not recruiting
  • Endometrial Endometrioid Adenocarcinoma
  • +4 more
  • Brachytherapy
  • +4 more
  • Birmingham, Alabama
  • +277 more
Sep 16, 2022

Moesin in Endometrial Hyperplasia and Endometrial Carcinoma

Not yet recruiting
  • Endometrial Cancer and Endometrial Hyperplasia
  • microscopic pathological evaluation
  • Sohag, Egypt
    Sohag University Hospital
Nov 8, 2022

Endometrial Carcinoma, Stage 0 Fallopian Tube Cancer AJCC v7, Stage I Fallopian Tube Cancer AJCC v6 and v7 Trial in New

Withdrawn
  • Endometrial Carcinoma
  • +55 more
  • Internet-Based Intervention
  • +3 more
  • New Brunswick, New Jersey
    Rutgers Cancer Institute of New Jersey
Apr 16, 2021

Endometrial Cancer Treatment Development

Completed
  • Endometrial Cancer Stage
    • Yunusemre, Mani̇sa, Turkey
      Manisa Celal Bayar University
    Jun 13, 2023

    Atypical Endometrial Hyperplasia, FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma, FIGO Grade 2 Endometrial Endometrioid

    Recruiting
    • Atypical Endometrial Hyperplasia
    • +2 more
    • Greeley, Colorado
    • +17 more
    Jun 13, 2022

    Staging Endometrial caNcer Based on molEcular ClAssification

    Recruiting
    • Endometrial Cancer
    • +2 more
      • Pamplona, Navarra, Spain
        Clinica Universidad de Navarra
      Jan 30, 2023

      Metastatic Endometrial Carcinoma, Recurrent Endometrial Carcinoma, Recurrent Fallopian Tube Carcinoma Trial (Biopsy, Biospecimen

      Not yet recruiting
      • Metastatic Endometrial Carcinoma
      • +7 more
      • Biopsy
      • +5 more
      • (no location specified)
      Jan 18, 2023

      Advanced Endometrial Carcinoma, Metastatic Endometrial Carcinoma, Recurrent Endometrial Carcinoma Trial in Canada, United States

      Active, not recruiting
      • Advanced Endometrial Carcinoma
      • +4 more
      • Cabozantinib S-malate
      • Nivolumab
      • Phoenix, Arizona
      • +33 more
      Nov 1, 2022

      Endometrial Adenocarcinoma, Endometrial Adenosquamous Carcinoma, Endometrial Clear Cell Adenocarcinoma Trial in United States

      Active, not recruiting
      • Endometrial Adenocarcinoma
      • +9 more
      • Bevacizumab
      • +5 more
      • Phoenix, Arizona
      • +232 more
      Jan 12, 2023

      Breast Tumors Trial in Saint Louis (accelerated partial breast irradiation)

      Active, not recruiting
      • Breast Neoplasms
      • accelerated partial breast irradiation
      • Saint Louis, Missouri
        Washington University School of Medicine
      Nov 14, 2022

      Endometrial Cancer, Uterine Carcinosarcoma Trial in New York, Bethlehem, Milwaukee (Rucaparib, Bevacizumab, Atezolizumab)

      Active, not recruiting
      • Endometrial Cancer
      • Uterine Carcinosarcoma
      • New York, New York
      • +2 more
      Apr 4, 2022

      Early Development of Endometrial Carcinoma

      Recruiting
      • Cancer of Endometrium
        • Ferrara, Italy
          Section of Obstetrics and Gynecology, Department of Morphology,
        Apr 4, 2022

        Chemo-refractory Colorectal Carcinoma Trial in Hamburg, Ulm (Maximum tolerated dose, MTD: D,L-methadone HCl (Methasan® 10

        Recruiting
        • Chemo-refractory Colorectal Carcinoma
        • Maximum tolerated dose, MTD: D,L-methadone hydrochloride (Methasan® 10 mg/ml)
        • Hamburg, Germany
        • +1 more
        Apr 21, 2022

        Neoadjuvant Therapy for Esophageal Squamous Cell Carcinoma

        Recruiting
        • Esophageal Squamous Cell Carcinoma
          • Shijiazhuang, Hebei, China
            Department of Thoracic Surgery, Fourth Hospital of Hebei Medical
          Oct 25, 2023